Arthritis drug tocilizumab reduces severe COVID-19 mortality
Telehealth use up markedly among Parkinson patients
11 February 2021Facing heat illness, dehydration risks, marching bands need access to athletic trainers
11 February 2021Arthritis drug tocilizumab reduces severe COVID-19 mortality
The arthritis drug tocilizumab reduces the risk of critically ill patients dying of COVID-19, according to results of a study on Thursday which experts welcomed as an “exciting” development.
